Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
about
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromesHematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age GroupsDynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCTAllogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party oMPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisRole of hematopoietic stem cell transplantation in patients with myeloproliferative disease.Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosisOutcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients.Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemiaNew Strategies in Myeloproliferative Neoplasms: The Evolving Genetic and Therapeutic Landscape.Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.Allogeneic stem cell transplantation for myelofibrosis in 2012.Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors.Myelofibrosis 2012: it's complicated.Allogeneic transplantation for myelofibrosis: for whom, when, and what are the true benefits?Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?Current Challenges in Stem Cell Transplantation in Myelofibrosis.Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation.Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis.Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning.Low-dose splenic irradiation prior to hematopoietic cell transplantation in hypersplenic patients with myelofibrosis.Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.Splenectomy prior to allogeneic hematopoietic SCT increases the risk of post-transplant lymphoproliferative disease.
P2860
Q26752940-83F1100D-972A-408E-889D-6BD31AA62877Q26786893-E65D8553-EA13-42DD-B1AD-D93894302CE1Q33400683-BDD2CE21-8081-4188-9322-3730FF1AE092Q33556843-6490DDDB-798A-4669-A443-56303346C44EQ33558748-C568D454-73E3-4AA0-91BD-EA332F23480CQ34047897-2D640B4A-ACDC-482B-88C5-0D0D42479870Q34625390-EB704DB5-92ED-4F2B-BF34-3B0D272BD6E7Q35735663-48D48BDB-9054-4320-B2E6-24A2921B53DAQ36166896-0B3CEE6D-8839-4306-AD9B-41840CD28770Q36404698-A4128CF3-7588-48EB-AF00-8ABD303B4719Q36782943-83B22D74-A821-4778-B679-2665BD6CA664Q37457111-500F3063-15BB-4631-9253-709F488D1449Q37998567-4BC57902-8770-42F0-8195-E1ED7B15D8B6Q38018908-F0046599-78C8-46F8-9325-ACD717264608Q38095967-DB2B2ED9-B64C-41C7-8559-E0E06AD8583EQ38174781-1C334DE6-772F-4178-8895-241773119B1DQ38349213-CA2FCCD2-7B37-42A3-A683-F09102A1F0AEQ38569146-650DACD0-F5D4-4807-ADBB-89EA45295E6AQ38570614-064190B1-841D-43D2-82ED-EABDF6D2B7AAQ38603384-2C00BD4E-5526-4AF8-8C44-950D62CBAA21Q39357992-D4037DB4-AB83-4F57-8369-FA39D33C345FQ40201370-6B5F7998-70C9-4E8E-900E-A828D0CAE5B5Q40261233-E274278E-3B89-4353-AE1B-B24B58C5E424Q40829969-0704A81F-F935-4729-8220-987913E5BAC1Q41519713-76DA1339-9E2D-4BA6-AE20-201C81756AB6Q43600843-0E908653-6EAE-4FA0-99A7-A68CEDC1DD52Q45060240-5F26124A-5990-459A-B368-C3505A1C6B2EQ53136705-E9624120-0541-4950-A014-69CD49946E9EQ54443654-D538D40B-7069-4A3C-9272-E9124E11AC56
P2860
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Allogeneic haematopoietic stem ...... Thérapie Cellulaire (SFGM-TC).
@ast
Allogeneic haematopoietic stem ...... Thérapie Cellulaire (SFGM-TC).
@en
type
label
Allogeneic haematopoietic stem ...... Thérapie Cellulaire (SFGM-TC).
@ast
Allogeneic haematopoietic stem ...... Thérapie Cellulaire (SFGM-TC).
@en
prefLabel
Allogeneic haematopoietic stem ...... Thérapie Cellulaire (SFGM-TC).
@ast
Allogeneic haematopoietic stem ...... Thérapie Cellulaire (SFGM-TC).
@en
P2093
P2860
P50
P1476
Allogeneic haematopoietic stem ...... Thérapie Cellulaire (SFGM-TC).
@en
P2093
Anne Huynh
Bernard Rio
Eric De Coninck
Jean-Yves Cahn
Karin Bilger
Marc Bernard
Marie Robin
Mauricette Michallet
Mohamad Mohty
Nathalie Contentin
P2860
P304
P356
10.1111/J.1365-2141.2010.08417.X
P407
P577
2010-12-07T00:00:00Z